المؤلفون: Hongxia Wang, Junjun Bai, Bei Zhang, Zhixin Pei, Yingxin Zhao, Jingjing Gu, Zhiyu Fang, Miaomiao Liu, Xun Liang, Qinglin Song

المصدر: Frontiers in Oncology, Vol 14 (2025)

مصطلحات موضوعية: ALK+ LBCL, alectinib, bortezomib, lenalidomide, BV monoclonal antibody, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2024.1480880/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/dcc97dc9b7c44ee591a497085d4f1f77

المؤلفون: Xiao, Andrew, Shahmarvand, Nahid, Nagy, Alexandra, Kumar, Jyoti, Van Ziffle, Jessica, Devine, Patrick, Huang, Franklin, Lezama, Lhara, Li, Peng, Ohgami, Robert S

مصطلحات موضوعية: ALK, ALK fusion, ALK translocation, ALK+ large B-cell lymphoma, TFG, Cancer, Rare Diseases, Lymphoma, Genetics, Hematology, Aetiology, 2.1 Biological and endogenous factors, ALK plus large B-cell lymphoma, Oncology and Carcinogenesis

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/00w6f58h
https://escholarship.org/content/qt00w6f58h/qt00w6f58h.pdf

المؤلفون: Muthiah Vaikundaraja Indhuja, Sivasree Kesana, Nikita Mehra, Parathan Karunakaran, Arun Kumar Rajan, Venkatraman Radhakrishnan, Perumal Kalaiyarasi Jayachandran

المصدر: South Asian Journal of Cancer, Vol 13, Iss 02, Pp 121-125 (2024)

مصطلحات موضوعية: ALK+ ALCL, anaplastic large cell lymphoma, crizotinib in ALCL, ALK inhibitors in ALCL, relapsed refractory ALCL, targeted therapy in NHL, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2278-330X; https://doaj.org/toc/2278-4306

URL الوصول: https://doaj.org/article/20f8ca09aa0a4cc29d696c0cefb09b6a

المؤلفون: Grace Chazan, M.B.B.S., BSc, FRACP, Fanny Franchini, BSc, MSc, DPhil, Roma Shah, MPH, Marliese Alexander, BPharm (Hons), MPH, PhD, Ani John, PhD, Maarten IJzerman, BSc, MSc, PhD, Benjamin Solomon, M.B.B.S., PhD, FRACP

المصدر: JTO Clinical and Research Reports, Vol 5, Iss 8, Pp 100662- (2024)

مصطلحات موضوعية: ALK+ lung cancer, Prognostic factors, Treatment sequence, Real-world, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666364324000328; https://doaj.org/toc/2666-3643

URL الوصول: https://doaj.org/article/3eb06d5d1ed3454a8a2475f9e0119edb

المؤلفون: Yinhui Liu, Yan Tan, Lin Hu, Jinlong Li, Jiansong Yang, Lei Diao, Jin Yang

المصدر: Frontiers in Pharmacology, Vol 15 (2024)

مصطلحات موضوعية: SAF-189s, population pharmacokinetics, exposure–response relationship, non-small cell lung cancer, ALK+, ROS1+, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2024.1418549/full; https://doaj.org/toc/1663-9812

URL الوصول: https://doaj.org/article/781117d2f18b49b1ad708847a0666c61

المؤلفون: Lee ATM, Ou SI

المصدر: Lung Cancer: Targets and Therapy, Vol Volume 15, Pp 19-27 (2024)

مصطلحات موضوعية: eml4-alk variant 3a/b, tp53 mutation, alk tkis, fifth generation alk tki, alk+ nsclc, circulating tumor dna, next-generation sequencing, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.dovepress.com/overcoming-central--sheet-6-c6-alk-mutation-l1256f-tp53-mutations-and--peer-reviewed-fulltext-article-LCTT; https://doaj.org/toc/1179-2728

URL الوصول: https://doaj.org/article/2546c96c26c048d3bbe7c62697e7dedb

المؤلفون: Presa M, Vicente D, Calles A, Salinas-Ortega L, Naik J, García LF, Soto J

المصدر: ClinicoEconomics and Outcomes Research, Vol Volume 15, Pp 659-671 (2023)

مصطلحات موضوعية: advanced non-small cell lung cancer, lorlatinib, alk+, cost-effectiveness analysis, cost-utility analysis, Medicine (General), R5-920, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.dovepress.com/cost-effectiveness-of-lorlatinib-for-the-treatment-of-adult-patients-w-peer-reviewed-fulltext-article-CEOR; https://doaj.org/toc/1178-6981

URL الوصول: https://doaj.org/article/19dc736b9da948ba87dcb5b2e01ec069

المؤلفون: Ou, Sai-Hong Ignatius, Nagasaka, Misako, Brazel, Danielle, Hou, Yujie, Zhu, Viola W

المصدر: Translational Oncology. 14(11)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Clinical Research, Cancer, Genetics, Lung Cancer, Lung, Clinical Trials and Supportive Activities, TPX-0131, NVL-655, "Single mutant active", "Double mutant active", ALK plus NSCLC, Anaplastic lymphoma kinase tyrosine kinase, inhibitors 4th-generation ALK TKI, 4th-generation ALK TKI, ALK+ NSCLC, Anaplastic lymphoma kinase tyrosine kinase inhibitors, “Double mutant active”, “Single mutant active”, Biochemistry and Cell Biology, Oncology & Carcinogenesis, Biochemistry and cell biology, Oncology and carcinogenesis

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/7rk5x7pc

المؤلفون: Lee AT, Ou SI

المصدر: Lung Cancer: Targets and Therapy, Vol Volume 14, Pp 57-62 (2023)

مصطلحات موضوعية: alta-3, alur, ascend-5, brigatinib, alectinib, ceritinib, crizotinib, advanced alk+ nsclc, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.dovepress.com/from-ascend-5-to-alur-to-alta-3-an-anti-climactic-end-to-the-era-of-ra-peer-reviewed-fulltext-article-LCTT; https://doaj.org/toc/1179-2728

URL الوصول: https://doaj.org/article/a4920faea99648adaa4cc549408017c6

المؤلفون: Andersen, Jon Lykkegaard, Johansen, Jakob Sidenius, Urbanska, Edyta Maria, Meldgaard, Peter, Hjorth-Hansen, Peter, Kristiansen, Charlotte, Stelmach, Miroslaw, Santoni-Rugiu, Eric, Ulhøi, Maiken Parm, Højgaard, Betina, Jensen, Morten Sall, Dydensborg, Anders Bondo, Dünweber, Christina, Hansen, Karin Holmskov

المصدر: Andersen , J L , Johansen , J S , Urbanska , E M , Meldgaard , P , Hjorth-Hansen , P , Kristiansen , C , Stelmach , M , Santoni-Rugiu , E , Ulhøi , M P , Højgaard , B , Jensen , M S , Dydensborg , A B , Dünweber , C & Hansen , K H 2024 , ' Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis ' , Lung Cancer Management , vol. 13 , no. 1 , LMT68 . https://doi.org/10.2217/lmt-2023-0013

مصطلحات موضوعية: ALK+, labor market affiliation, nationwide, non-small-cell lung cancer, prevalence, retrospective, return to work

Relation: https://pure.au.dk/portal/en/publications/b8905fb3-cf29-47e1-8964-b31671b858ac

الاتاحة: https://pure.au.dk/portal/en/publications/b8905fb3-cf29-47e1-8964-b31671b858ac
https://doi.org/10.2217/lmt-2023-0013

المؤلفون: Lee ATM, Ou SI

المصدر: Lung Cancer: Targets and Therapy, Vol Volume 15, Pp 19-27 (2024)

مصطلحات موضوعية: eml4-alk variant 3a/b, tp53 mutation, alk tkis, fifth generation alk tki, alk+ nsclc, circulating tumor dna, next-generation sequencing, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

Relation: https://www.dovepress.com/overcoming-central--sheet-6-c6-alk-mutation-l1256f-tp53-mutations-and--peer-reviewed-fulltext-article-LCTT; https://doaj.org/toc/1179-2728; https://doaj.org/article/2546c96c26c048d3bbe7c62697e7dedb

الاتاحة: https://doaj.org/article/2546c96c26c048d3bbe7c62697e7dedb

المؤلفون: Zhu, Viola, Nagasaka, Misako, Madison, Russell, Schrock, Alexa, Cui, Jean, Ou, Sai-Hong

المصدر: JTO Clinical and Research Reports. 2(1)

مصطلحات موضوعية: ALK+ NSCLC, Double mutation, G1202R, Lorlatinib resistance, S1206Y

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/64x00928

المؤلفون: Ou, Sai-Hong, Zhu, Viola, Nagasaka, Misako

المصدر: JTO Clinical and Research Reports. 1(1)

مصطلحات موضوعية: ALK fusion partners, ALK+ NSCLC, Next-generation sequencing, Whole transcriptome sequencing

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/9jf869kx

المؤلفون: Hitoshi Ohno

المصدر: Tenri Medical Bulletin. 2023, 26(1):32

المؤلفون: Minsuk Kwon, Bo mi Ku, Steve Olsen, Sehhoon Park, Martina Lefterova, Justin Odegaard, Hyun‐Ae Jung, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn

المصدر: Cancer Medicine, Vol 11, Iss 15, Pp 2944-2956 (2022)

مصطلحات موضوعية: anaplastic lymphoma kinase‐rearranged (ALK+) NSCLC, cell‐free DNA, liquid biopsy, next‐generation sequencing, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2045-7634

URL الوصول: https://doaj.org/article/8eb3dae224764b56b6cda174cd528194

المؤلفون: Loélia Babin, Alice Darchen, Elie Robert, Zakia Aid, Rosalie Borry, Claire Soudais, Marion Piganeau, Anne De Cian, Carine Giovannangeli, Olivia Bawa, Charlotte Rigaud, Jean-Yves Scoazec, Lucile Couronné, Layla Veleanu, Agata Cieslak, Vahid Asnafi, David Sibon, Laurence Lamant, Fabienne Meggetto, Thomas Mercher, Erika Brunet

المصدر: Molecular Cancer, Vol 21, Iss 1, Pp 1-18 (2022)

مصطلحات موضوعية: ALK+ ALCL, Lymphoma, NPM-ALK fusion, CRISPR/Cas9 models, WNT, ROR2, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1476-4598

URL الوصول: https://doaj.org/article/a1c4dd48d3b24f998de122fdb6715403

المؤلفون: Andrew Xiao, Nahid Shahmarvand, Alexandra Nagy, Jyoti Kumar, Jessica Van Ziffle, Patrick Devine, Franklin Huang, Lhara Lezama, Peng Li, Robert S. Ohgami

المصدر: Frontiers in Oncology, Vol 13 (2023)

مصطلحات موضوعية: ALK+ large B-cell lymphoma, TFG, ALK, ALK translocation, ALK fusion, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2023.1174606/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/03c6998d8089436e9c52ba034407c755

المؤلفون: Zihua Zou, Xuezhi Hao, Cuiying Zhang, Haojing Li, Guilan Dong, Yumei Peng, Kewei Ma, Ye Guo, Li Shan, Yan Zhang, Li Liang, Yangchun Gu, Puyuan Xing, Junling Li

المصدر: Thoracic Cancer, Vol 13, Iss 1, Pp 107-116 (2022)

مصطلحات موضوعية: Alectinib, ALK+ NSCLC, Crizotinib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1759-7706; https://doaj.org/toc/1759-7714

URL الوصول: https://doaj.org/article/87d7d152cdcc469aafecd2b00aea35e7

المؤلفون: Dan Que, Hongbo Zou, Bijing Mao, Huan Zhang, Wei Liang, Qin Liu, Leiyu Ke, Lijie Guo, Qichao Xie

المصدر: Frontiers in Oncology, Vol 12 (2022)

مصطلحات موضوعية: multiple lines of therapy, lung adenocarcinoma, pathological complete remission, targeted therapy, ALK+, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2022.967675/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/bdf3e7a48354485db462926a964d7fd0

المؤلفون: Petros Christopoulos, Farastuk Bozorgmehr, Lena Brückner, Inn Chung, Johannes Krisam, Marc A. Schneider, Albrecht Stenzinger, Regina Eickhoff, Daniel W. Mueller, Michael Thomas

المصدر: BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)

مصطلحات موضوعية: Non-small cell lung cancer, Anaplastic lymphoma kinase, ALK+ NSCLC, Tyrosine kinase inhibitors (TKI), Brigatinib, Resistance mutations, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1471-2407

URL الوصول: https://doaj.org/article/4e6781e44b744b6b9128b4b4f1cc88df